{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:24:07Z","timestamp":1794273847520,"version":"4.9.0"},"reference-count":210,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":389,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jacc.2024.11.023","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T14:17:09Z","timestamp":1736777829000},"page":"1213-1285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":135,"title":["ACC\/AHA\/ASE\/HFSA\/HRS\/SCAI\/SCCT\/SCMR 2025 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Pacing"],"prefix":"10.1016","volume":"85","author":[{"given":"Andrea M.","family":"Russo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milind Y.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika M.","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina K.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew E.","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya E.","family":"Guglin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne C.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P.","family":"Piccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Bhave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milind Y.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika M.","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrut V.","family":"Ambardekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy C.","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth C.","family":"Bilchick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"G. William","family":"Dec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Gopinathannair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet K.","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liviu","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel J.","family":"Lampert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurusher S.","family":"Panjrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan R.","family":"Reeves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danita Marie","family":"Yoerger Sanborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne W.","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quynh A.","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Varosy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd C.","family":"Villines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle S.","family":"Volgman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina M.","family":"Zareba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2024.11.023_bib1","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jacc.2012.12.017","volume":"61","author":"Russo","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib2","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.hrthm.2023.03.1538","article-title":"2023 HRS\/APHRS\/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure","volume":"20","author":"Chung","year":"2023","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2024.11.023_bib3","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jacc.2018.01.007","article-title":"ACC appropriate use criteria methodology: 2018 update: a report of the American College of Cardiology Appropriate Use Criteria Task Force","volume":"71","author":"Hendel","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib4","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jacc.2017.10.054","volume":"72","author":"Al-Khatib","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib5","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.02.032","volume":"51","author":"Epstein","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib6","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/j.jacc.2012.12.014","volume":"61","author":"Epstein","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib7","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.jacc.2018.10.044","volume":"74","author":"Kusumoto","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib8","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1093\/eurheartj\/ehab364","article-title":"2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy","volume":"42","author":"Glikson","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.023_bib9","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jacc.2016.03.513","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"68","author":"Levine","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib10","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.jacc.2014.07.017","volume":"64","author":"Fihn","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib11","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2012.07.013","volume":"60","author":"Fihn","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib12","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","volume":"70","author":"Yancy","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib13","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib15","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.hrthm.2011.04.015","article-title":"Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival","volume":"8","author":"Hayes","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2024.11.023_bib16","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/j.hrthm.2015.11.018","article-title":"2015 HRS\/EHRA\/APHRS\/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing","volume":"13","author":"Wilkoff","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2024.11.023_bib17","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.hrthm.2010.10.035","article-title":"Long-term implications of cumulative right ventricular pacing among patients with an implantable cardioverter-defibrillator","volume":"8","author":"Barsheshet","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2024.11.023_bib18","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1001\/jama.288.24.3115","article-title":"Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the dual chamber and VVI implantable defibrillator (DAVID) trial","volume":"288","author":"Wilkoff","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.023_bib19","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1161\/01.CIR.0000072769.17295.B1","article-title":"Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction","volume":"107","author":"Sweeney","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.023_bib20","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.hrthm.2005.05.015","article-title":"Percent right ventricular pacing predicts outcomes in the DAVID trial","volume":"2","author":"Sharma","year":"2005","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2024.11.023_bib21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1046\/j.1540-8167.2005.50038.x","article-title":"The clinical implications of cumulative right ventricular pacing in the multicenter automatic defibrillator trial II","volume":"16","author":"Steinberg","year":"2005","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib22","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.hrthm.2012.06.026","article-title":"HRS\/ACCF expert consensus statement on pacemaker device and mode selection. Developed in partnership between the Heart Rhythm Society (HRS) and the American College of Cardiology Foundation (ACCF) and in collaboration with the Society of Thoracic Surgeons","volume":"9","author":"Gillis","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2024.11.023_bib23","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ijcard.2007.02.041","article-title":"Prevention of inappropriate therapy in implantable defibrillators: A meta-analysis of clinical trials comparing single-chamber and dual-chamber arrhythmia discrimination algorithms","volume":"125","author":"Theuns","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib24","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.hlc.2015.07.008","article-title":"Efficiencies and complications of dual chamber versus single chamber implantable cardioverter defibrillators in secondary sudden cardiac death Prevention: a meta-analysis","volume":"25","author":"Hu","year":"2016","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.jacc.2024.11.023_bib25","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jacc.2011.04.039","article-title":"Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry","volume":"58","author":"Dewland","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib26","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/europace\/euu022","article-title":"A\u00a0prospective randomized trial of single- or dual-chamber implantable cardioverter-defibrillators to minimize inappropriate shock risk in primary sudden cardiac death prevention","volume":"16","author":"Friedman","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2024.11.023_bib27","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1001\/jama.2013.4982","article-title":"Association of single- vs dual-chamber ICDs with mortality, readmissions, and complications among patients receiving an ICD for primary prevention","volume":"309","author":"Peterson","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.023_bib28","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/j.jacc.2017.03.568","article-title":"Seattle heart failure and proportional risk models predict benefit from implantable cardioverter-defibrillators","volume":"69","author":"Bilchick","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib29","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jchf.2019.03.019","article-title":"Risk models for prediction of implantable cardioverter-defibrillator benefit: insights from the DANISH trial","volume":"7","author":"Kristensen","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2024.11.023_bib30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jacep.2015.12.004","article-title":"COCATS 4, the 2015 CCEP advanced training statement, and the transition from 12 to 24 required months of electrophysiology training:rationale, status, and implications for the future","volume":"2","author":"Patton","year":"2016","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib31","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/j.hrthm.2013.01.035","article-title":"The national ICD registry report: version 2.1 including leads and pediatrics for years 2010 and 2011","volume":"10","author":"Kremers","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2024.11.023_bib32","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1161\/CIRCULATIONAHA.124.069568","article-title":"Sodium-glucose cotransporter-2 inhibitors and major adverse cardiovascular outcomes: A SMART-C collaborative meta-analysis","volume":"149","author":"Patel","year":"2024","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.jacc.2024.11.023_bib33","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.jacc.2024.11.023_bib34","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cardfail.2021.01.022","volume":"27","author":"Bozkurt","year":"2021","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2024.11.023_bib35","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.11.013","volume":"53","author":"Hunt","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jacc.2017.11.025","volume":"71","author":"Yancy","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib37","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib38","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jacc.2012.08.001","article-title":"Third universal definition of myocardial infarction","volume":"60","author":"Thygesen","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib39","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/eurheartj\/ehq456","article-title":"Troponin elevation in coronary vs. non-coronary disease","volume":"32","author":"Agewall","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.023_bib40","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.jacc.2006.10.014","article-title":"Troponin trumps common sense","volume":"48","author":"Fye","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib41","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1056\/NEJMoa041489","article-title":"Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction","volume":"351","author":"Hohnloser","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.023_bib42","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJM199711273372202","article-title":"A\u00a0comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias","volume":"337","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.023_bib43","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1161\/01.CIR.101.11.1297","article-title":"Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone","volume":"101","author":"Connolly","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.023_bib44","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/01.CIR.102.7.748","article-title":"Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest","volume":"102","author":"Kuck","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.023_bib45","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1053\/euhj.2000.2476","article-title":"Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study","volume":"21","author":"Connolly","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.023_bib46","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.jacc.2005.01.031","article-title":"Mortality reduction by implantable cardioverter-defibrillators in high-risk patients with heart failure, ischemic heart disease, and new-onset ventricular arrhythmia: an effectiveness study","volume":"45","author":"Chan","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib47","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jacep.2016.06.001","article-title":"Survival after secondary prevention implantable cardioverter-defibrillator placement: an analysis from the NCDR ICD registry","volume":"3","author":"Katz","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib48","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/europace\/euv188","article-title":"Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication","volume":"18","author":"Schaer","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2024.11.023_bib49","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.023_bib50","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/S0735-1097(01)01597-2","article-title":"Life-threatening ventricular arrhythmias due to transient or correctable causes: high risk for death in follow-up","volume":"38","author":"Wyse","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib51","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1161\/CIRCULATIONAHA.109.924225","article-title":"Mechanisms underlying the lack of effect of implantable cardioverter-defibrillator therapy on mortality in high-risk patients with recent myocardial infarction: insights from the defibrillation in acute myocardial infarction trial (DINAMIT)","volume":"122","author":"Dorian","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.023_bib52","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1056\/NEJMoa0901889","article-title":"Defibrillator implantation early after myocardial infarction","volume":"361","author":"Steinbeck","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.023_bib53","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.jacc.2007.09.011","article-title":"Universal definition of myocardial infarction","volume":"50","author":"Thygesen","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib54","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1056\/NEJM199912163412503","article-title":"A\u00a0Randomized study of the prevention of sudden death in patients with coronary artery disease","volume":"341","author":"Buxton","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.023_bib55","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.023_bib56","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1046\/j.1540-8167.2002.00757.x","article-title":"Prognostic significance of nonsustained ventricular tachycardia identified postoperatively after coronary artery bypass surgery in patients with left ventricular dysfunction","volume":"13","author":"Pires","year":"2002","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib57","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1161\/CIRCULATIONAHA.110.976076","article-title":"Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry","volume":"122","author":"Poole","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.023_bib58","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.jacc.2014.04.008","article-title":"HRS\/ACC\/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials","volume":"64","author":"Kusumoto","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib59","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.023_bib60","series-title":"Arrhythmia Treatment and Therapy: Evaluation of Clinical Trial Evidence","first-page":"323","article-title":"The sudden cardiac death-heart failure trial (SCD-HeFT)","author":"Bardy","year":"2000"},{"key":"10.1016\/j.jacc.2024.11.023_bib61","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1161\/CIRCOUTCOMES.114.001306","article-title":"Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients","volume":"8","author":"Hess","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2024.11.023_bib62","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jchf.2014.06.007","article-title":"Outcomes of implantable cardioverter-defibrillator use in patients with comorbidities: results from a combined analysis of 4 randomized clinical trials","volume":"2","author":"Steinberg","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2024.11.023_bib63","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1161\/CIRCULATIONAHA.117.028829","article-title":"Age and outcomes of primary prevention implantable cardioverter-defibrillators in patients with nonischemic systolic heart failure","volume":"136","author":"Elming","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.023_bib64","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"K\u00f8ber","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.023_bib65","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.023_bib66","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1161\/CIRCULATIONAHA.116.026910","article-title":"Association between midwall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction","volume":"135","author":"Halliday","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.023_bib67","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1532-429X-14-28","article-title":"Cardiovascular magnetic resonance in systemic hypertension","volume":"14","author":"Maceira","year":"2012","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.jacc.2024.11.023_bib68","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1161\/CIRCIMAGING.113.001144","article-title":"Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis","volume":"7","author":"Kuruvilla","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2024.11.023_bib69","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ahj.2019.10.020","article-title":"Myocardial fibrosis and the effect of primary prophylactic defibrillator implantation in patients with non-ischemic systolic heart failure\u2014DANISH-MRI","volume":"221","author":"Elming","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2024.11.023_bib70","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/01.CIR.0000140259.16185.7D","article-title":"The 1+1 trial: a prospective trial of a dual- versus a single-chamber implantable defibrillator in patients with slow ventricular tachycardias","volume":"110","author":"B\u00e4nsch","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.023_bib71","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy","volume":"350","author":"Kadish","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.023_bib72","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"34","author":"Caforio","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.023_bib73","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1016\/j.hrthm.2019.05.007","article-title":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy","volume":"16","author":"Towbin","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2024.11.023_bib74","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1161\/CIRCOUTCOMES.114.001306","article-title":"Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials","volume":"8","author":"Hess","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2024.11.023_bib75","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2337\/dc19-1014","article-title":"Appropriate shocks and mortality in patients with versus without diabetes with prophylactic implantable cardioverter defibrillators","volume":"43","author":"Junttila","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2024.11.023_bib76","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/ejhf.1192","article-title":"Implantable cardioverter-defibrillators in heart failure patients with reduced ejection fraction and diabetes","volume":"20","author":"Sharma","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2024.11.023_bib77","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jamainternmed.2017.8462","article-title":"Long-term outcomes associated with implantable cardioverter defibrillator in adults with chronic kidney disease","volume":"178","author":"Bansal","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2024.11.023_bib78","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/j.ajkd.2013.12.009","article-title":"Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials","volume":"64","author":"Pun","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2024.11.023_bib79","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/j.jacc.2007.02.058","article-title":"Effect of cardiac and noncardiac conditions on survival after defibrillator implantation","volume":"49","author":"Lee","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib80","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ijcard.2015.10.080","article-title":"Do we need further clinical-effectiveness estimates to support the use of primary prevention implantable cardioverter-defibrillators in New York Heart Association class III patients?","volume":"203","author":"Barra","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib81","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1016\/j.jacc.2014.02.602","article-title":"Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (sudden cardiac death in heart failure trial)","volume":"63","author":"Fishbein","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib82","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jacep.2016.04.013","article-title":"Implications of frailty in elderly patients with electrophysiological conditions","volume":"2","author":"Bibas","year":"2016","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib83","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1161\/CIRCULATIONAHA.110.940148","article-title":"Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: an extended 8-year follow-up study of the multicenter automatic defibrillator implantation trial II","volume":"122","author":"Goldenberg","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.023_bib84","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jacc.2007.08.058","article-title":"Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction","volume":"51","author":"Goldenberg","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib85","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jacep.2018.04.015","article-title":"Improving the use of primary prevention implantable cardioverter-defibrillators therapy with validated patient-centric risk estimates","volume":"4","author":"Levy","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib86","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1093\/eurheartj\/ehaa226","article-title":"Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study","volume":"41","author":"Zabel","year":"2020","journal-title":"Eur Heart Jl"},{"key":"10.1016\/j.jacc.2024.11.023_bib87","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jacep.2016.09.006","article-title":"Does the implantable cardioverter-defibrillator benefit vary with the estimated proportional risk of sudden death in heart failure patients?","volume":"3","author":"Levy","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib88","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.hrthm.2015.06.039","article-title":"A\u00a0novel method to predict the proportional risk of sudden cardiac death in heart failure: Derivation of the Seattle proportional risk model","volume":"12","author":"Shadman","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2024.11.023_bib89","first-page":"208","article-title":"Benefits of ICD therapy: connecting treatment decisions to individualized SCD risk estimates within SCD-HeFT\u2014Seattle Proportional Risk Model (abstract)","volume":"42","author":"Levy","year":"2015","journal-title":"J\u00a0Inter Card Electrophysiology"},{"key":"10.1016\/j.jacc.2024.11.023_bib90","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1161\/CIRCULATIONAHA.108.816884","article-title":"Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population","volume":"120","author":"Levy","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.023_bib91","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.jacc.2012.02.036","article-title":"Applicability of a risk score for prediction of the long-term (8-year) benefit of the implantable cardioverter-defibrillator","volume":"59","author":"Barsheshet","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib92","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1161\/CIRCULATIONAHA.119.039818","article-title":"Prophylactic use of implantable cardioverter-defibrillators in the prevention of sudden cardiac death in dialysis patients","volume":"139","author":"Jukema","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.023_bib93","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/eurheartj\/ehy437","article-title":"Reduction in mortality from implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy patients is dependent on the presence of left ventricular scar","volume":"40","author":"Gutman","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.023_bib94","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.jacc.2012.07.028","article-title":"Prediction of mortality in clinical practice for medicare patients undergoing defibrillator implantation for primary prevention of sudden cardiac death","volume":"60","author":"Bilchick","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib95","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1161\/CIRCHEARTFAILURE.115.002414","article-title":"Clinical risk stratification for primary prevention implantable cardioverter defibrillators","volume":"8","author":"Lee","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2024.11.023_bib96","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.ahj.2003.12.017","article-title":"Diminishing proportional risk of sudden death with advancing age: implications for prevention of sudden death","volume":"147","author":"Krahn","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2024.11.023_bib97","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/CIRCULATIONAHA.106.687103","article-title":"Prediction of mode of death in heart failure: the Seattle heart failure model","volume":"116","author":"Mozaffarian","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.023_bib98","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.cardfail.2017.11.002","article-title":"Predicting survival in patients with heart failure with an implantable cardioverter defibrillator: The Heart Failure Meta-Score","volume":"24","author":"Alba","year":"2018","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2024.11.023_bib99","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","article-title":"Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators","volume":"335","author":"Moss","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.023_bib100","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.hrthm.2009.04.010","article-title":"Implantable cardioverter-defibrillator prescription in the elderly","volume":"6","author":"Epstein","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2024.11.023_bib101","unstructured":"American College of Cardiology Foundation. NCDR ICD Registry Institutional Outcomes Report 2020Q4.\u00a02020."},{"key":"10.1016\/j.jacc.2024.11.023_bib102","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1540-8159.2007.00651.x","article-title":"Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death","volume":"30","author":"Cuculich","year":"2007","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib103","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.amjcard.2010.06.058","article-title":"Effect of renal function on survival after implantable cardioverter defibrillator placement","volume":"106","author":"Hager","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib104","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/pace.14411","article-title":"Implantable cardioverter-defibrillators with end stage renal disease: nationwide inpatient sample database results","volume":"45","author":"Ayoub","year":"2022","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib105","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1540-8167.2011.02066.x","article-title":"End-stage renal disease predicts complications in pacemaker and ICD implants","volume":"22","author":"Tompkins","year":"2011","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib106","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.hrthm.2020.04.036","article-title":"Outcomes of subcutaneous implantable cardioverter-defibrillator in dialysis patients: results from the S-ICD post-approval study","volume":"17","author":"El-Chami","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2024.11.023_bib107","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jacep.2019.08.009","article-title":"Risk of ventricular tachyarrhythmic events in patients who improved beyond guidelines for a defibrillator in MADIT-CRT","volume":"5","author":"Sherazi","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib108","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/pace.12174","article-title":"Normalization of left ventricular ejection fraction after cardiac resynchronization therapy also normalizes survival","volume":"36","author":"Manne","year":"2013","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib109","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10840-017-0222-1","article-title":"Risk of ventricular tachyarrhythmias following improvement of left ventricular ejection fraction in patients with implantable cardiac defibrillators implanted for primary prevention of sudden cardiac death","volume":"48","author":"Pillarisetti","year":"2017","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib110","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.hrthm.2013.02.017","article-title":"Significance of follow-up left ventricular ejection fraction measurements in the defibrillators in non-ischemic cardiomyopathy treatment evaluation trial (DEFINITE)","volume":"10","author":"Schliamser","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2024.11.023_bib111","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/europace\/euw230","article-title":"Dual- vs. single-chamber defibrillators for primary prevention of sudden cardiac death: long-term follow-up of the d\u00e9fibrillateur automatique implantable-pr\u00e9vention primaire registry","volume":"19","author":"Defaye","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2024.11.023_bib112","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1046\/j.1540-8167.2001.00134.x","article-title":"Do current dual chamber cardioverter defibrillators have advantages over conventional single chamber cardioverter defibrillators in reducing inappropriate therapies? A randomized, prospective study","volume":"12","author":"Deisenhofer","year":"2001","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib113","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1540-8167.1999.tb01261.x","article-title":"Clinical experience with the new detection algorithms for atrial fibrillation of a defibrillator with dual chamber sensing and pacing","volume":"10","author":"K\u00fchlkamp","year":"1999","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib114","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1540-8167.2008.01322.x","article-title":"Inappropriate ICD discharges in single-chamber versus dual-chamber devices in the pediatric and young adult population","volume":"20","author":"Lawrence","year":"2009","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"12","key":"10.1016\/j.jacc.2024.11.023_bib115","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/j.jacc.2004.09.039","article-title":"Prevention of inappropriate therapy in implantable cardioverter-defibrillators: results of a prospective, randomized study of tachyarrhythmia detection algorithms","volume":"44","author":"Theuns","year":"2004","journal-title":"J\u00a0Am Coll of Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib116","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/jce.12099","article-title":"Frequency of inappropriate therapy in patients implanted with dual- versus single-chamber ICD devices in the ICD arm of MADIT-CRT","volume":"24","author":"Ruwald","year":"2013","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib117","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10840-018-0494-0","article-title":"Single-brand dual-chamber discriminators to prevent inappropriate shocks in patients implanted with prophylactic implantable cardioverter defibrillators: a propensity-weighted comparison of single- and dual-chamber devices","volume":"54","author":"Briongos-Figuero","year":"2019","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib118","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1161\/CIRCULATIONAHA.105.594531","article-title":"Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study","volume":"113","author":"Friedman","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.023_bib119","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1001\/archinternmed.2012.394","article-title":"Variation in use of dual-chamber implantable cardioverter-defibrillators: results from the national cardiovascular data registry","volume":"172","author":"Matlock","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2024.11.023_bib120","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.3429","article-title":"Trends in use of single- vs dual-chamber implantable cardioverter-defibrillators among patients without a pacing indication, 2010-2018","volume":"5","author":"Borne","year":"2022","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.jacc.2024.11.023_bib121","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1161\/CIRCULATIONAHA.106.663807","article-title":"Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years","volume":"115","author":"Kleemann","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.023_bib122","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1161\/CIRCULATIONAHA.108.776807","article-title":"Implantable cardioverter-defibrillator lead performance","volume":"117","author":"Maisel","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.023_bib123","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/CIRCULATIONAHA.113.003042","article-title":"Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator","volume":"128","author":"Weiss","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.023_bib124","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1001\/jamacardio.2016.2782","article-title":"Trends and in-hospital outcomes associated with adoption of the subcutaneous implantable cardioverter defibrillator in the United States","volume":"1","author":"Friedman","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib125","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jacc.2017.06.040","article-title":"Implant and midterm outcomes of the subcutaneous implantable cardioverter-defibrillator registry: the EFFORTLESS study","volume":"70","author":"Boersma","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib126","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.jacc.2015.02.047","article-title":"Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-Year results from a pooled analysis of the IDE study and EFFORTLESS registry","volume":"65","author":"Burke","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib127","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.hrthm.2021.07.008","article-title":"Long-term complications in patients implanted with subcutaneous implantable cardioverter-defibrillators: real-world data from the extended ELISIR experience","volume":"18","author":"Gasperetti","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2024.11.023_bib128","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.jacep.2017.07.017","article-title":"Subcutaneous versus transvenous implantable defibrillator therapy: a meta-analysis of case-control studies","volume":"3","author":"Basu-Ray","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib129","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.7326\/M22-1566","article-title":"Perioperative safety and early patient and device outcomes among subcutaneous versus transvenous implantable cardioverter defibrillator implantations","volume":"175","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2024.11.023_bib130","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJMoa1915932","article-title":"Subcutaneous or Transvenous Defibrillator Therapy","volume":"383","author":"Knops","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.023_bib131","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.hrthm.2019.04.048","article-title":"Understanding Outcomes with the EMBLEM S-ICD in Primary Prevention Patients with Low EF Study (UNTOUCHED): Clinical characteristics and perioperative results","volume":"16","author":"Boersma","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2024.11.023_bib132","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.120.048728","article-title":"Primary results from the understanding outcomes with the S-ICD in primary prevention patients with low ejection fraction (UNTOUCHED) trial","volume":"143","author":"Gold","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.023_bib133","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2401807","article-title":"A\u00a0modular communicative leadless pacing-defibrillator system","volume":"391","author":"Knops","year":"2024","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.023_bib134","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1161\/CIRCULATIONAHA.110.960898","article-title":"Effectiveness of cardiac resynchronization therapy by QRS morphology in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT)","volume":"123","author":"Zareba","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.023_bib135","doi-asserted-by":"crossref","first-page":"e283","DOI":"10.1161\/CIR.0b013e318276ce9b","article-title":"2012 ACCF\/AHA\/HRS Focused update incorporated into the ACCF\/AHA\/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities","volume":"127","author":"Epstein","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.023_bib136","first-page":"e85","article-title":"Right ventricular tachycardia","volume":"128","author":"Menon","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.023_bib137","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004478","article-title":"Waiting period before implantable cardioverter-defibrillator implantation in newly diagnosed heart failure with reduced ejection fraction: a window of opportunity","volume":"10","author":"DeFilippis","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2024.11.023_bib138","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.jacc.2011.05.033","article-title":"Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: results of the IMAC (intervention in myocarditis and acute cardiomyopathy)-2 study","volume":"58","author":"McNamara","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib139","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jacc.2017.11.020","article-title":"Impaired recovery of left ventricular function in patients with cardiomyopathy and left bundle branch block","volume":"71","author":"Sze","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib140","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.hrthm.2015.12.020","article-title":"New-onset left bundle branch block-associated idiopathic nonischemic cardiomyopathy and left ventricular ejection fraction response to guideline-directed therapies: the NEOLITH study","volume":"13","author":"Wang","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2024.11.023_bib141","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jcmg.2017.04.021","article-title":"Scar characterization to predict life-threatening arrhythmic events and sudden cardiac death in patients with cardiac resynchronization therapy: The GAUDI-CRT study","volume":"11","author":"Acosta","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2024.11.023_bib142","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/europace\/euaa414","article-title":"Risk of ventricular arrhythmia in cardiac resynchronization therapy responders and super-responders: a systematic review and meta-analysis","volume":"23","author":"Yuyun","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2024.11.023_bib143","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/europace\/euad044","article-title":"EHRA clinical consensus statement on conduction system pacing implantation: executive summary. Endorsed by the Asia-Pacific Heart Rhythm Society (APHRS), Canadian Heart Rhythm Society (CHRS) and Latin-American Heart Rhythm Society (LAHRS)","volume":"25","author":"Burri","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2024.11.023_bib144","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1056\/NEJMoa2304542","article-title":"Long-term outcomes of resynchronization-defibrillation for heart failure","volume":"390","author":"Sapp","year":"2024","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.023_bib145","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.hrthm.2014.05.040","article-title":"Incidence and predictors of right ventricular pacing-induced cardiomyopathy","volume":"11","author":"Khurshid","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2024.11.023_bib146","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.hrthm.2021.06.1195","article-title":"Leadless left ventricular stimulation with WiSE-CRT System \u2013 initial experience and results from phase I of SOLVE-CRT study (nonrandomized, roll-in phase)","volume":"19","author":"Okabe","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2024.11.023_bib147","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijcard.2016.07.257","article-title":"The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices - a meta-analysis","volume":"222","author":"Agrawal","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib148","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1016\/j.jacc.2013.04.020","article-title":"Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices: need for primary prevention?","volume":"61","author":"Garan","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib149","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/pace.12654","article-title":"Impact of implantable cardioverter defibrillators on survival of patients with centrifugal left ventricular assist devices","volume":"38","author":"Lee","year":"2015","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib150","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ijcard.2016.12.148","article-title":"Presence of implantable cardioverter-defibrillators and wait-list mortality of patients supported with left ventricular assist devices as bridge to heart transplantation","volume":"231","author":"Younes","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib151","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.healun.2013.11.005","article-title":"Low cardiac output associated with ventricular tachyarrhythmias in continuous-flow LVAD recipients with a concomitant ICD (LoCo VT Study)","volume":"33","author":"Cantillon","year":"2014","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2024.11.023_bib152","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.cardfail.2011.10.020","article-title":"Survival benefit of implantable cardioverter-defibrillators in left ventricular assist device-supported heart failure patients","volume":"18","author":"Refaat","year":"2012","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2024.11.023_bib153","doi-asserted-by":"crossref","first-page":"e967","DOI":"10.1161\/CIR.0000000000000673","article-title":"Device therapy and arrhythmia management in left ventricular assist device recipients: a scientific statement from the American Heart Association","volume":"139","author":"Gopinathannair","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.023_bib154","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/ehf2.12255","article-title":"Subcutaneous implantable cardioverter defibrillator in patients awaiting cardiac transplantation or left ventricular assist device for refractory heart failure: a feasible alternative to transvenous device?","volume":"5","author":"Migliore","year":"2018","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacc.2024.11.023_bib155","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.jacep.2018.05.002","article-title":"Multicenter experience of concomitant use of left ventricular assist devices and subcutaneous implantable cardioverter-defibrillators","volume":"4","author":"Afzal","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib156","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jtcvs.2016.09.084","article-title":"Are biventricular assist devices underused as a bridge to heart transplantation in patients with a high risk of postimplant right ventricular failure?","volume":"153","author":"Bartfay","year":"2017","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2024.11.023_bib157","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.cardfail.2014.12.006","article-title":"Impact of cardiac resynchronization therapy on clinical outcomes in patients with continuous-flow left ventricular assist devices","volume":"21","author":"Gopinathannair","year":"2015","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2024.11.023_bib158","article-title":"Cardiac resynchronization therapy and clinical outcomes in continuous flow left ventricular assist device recipients","volume":"7","author":"Gopinathannair","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2024.11.023_bib159","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/MAT.0000000000000787","article-title":"Impact of cardiac resynchronization therapy on left ventricular unloading in patients with implanted left ventricular assist devices","volume":"65","author":"Tehrani","year":"2019","journal-title":"Asaio j"},{"key":"10.1016\/j.jacc.2024.11.023_bib160","article-title":"Impact of cardiac resynchronization therapy on ventricular arrhythmias and survival after durable left ventricular assist device implantation","author":"Oates","year":"2024","journal-title":"Asaio j"},{"key":"10.1016\/j.jacc.2024.11.023_bib161","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jacep.2021.01.016","article-title":"Biventricular pacing versus right ventricular pacing in patients supported with LVAD","volume":"7","author":"Chung","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib162","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/jce.16142","article-title":"Managing ventricular arrhythmias and implantable cardiac defibrillator shocks after left ventricular assist device implantation","volume":"35","author":"Soni","year":"2024","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib163","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.hrthm.2014.07.016","article-title":"Incidence, predictors, and temporal trends of sudden cardiac death after heart transplantation","volume":"11","author":"Vakil","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2024.11.023_bib164","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.hrthm.2009.01.005","article-title":"Mode and mechanisms of death after orthotopic heart transplantation","volume":"6","author":"Vaseghi","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2024.11.023_bib165","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13490","article-title":"The evolving risk of sudden cardiac death after heart transplant. An analysis of the ISHLT thoracic transplant registry","volume":"33","author":"Alba","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jacc.2024.11.023_bib166","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.healun.2009.01.011","article-title":"Sudden cardiac death of two heart transplant patients with correctly functioning implantable cardioverter defibrillators","volume":"28","author":"Marzoa-Rivas","year":"2009","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2024.11.023_bib167","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.healun.2015.12.011","article-title":"Implantable cardioverter-defibrillators in a heart transplant population: a single-center experience","volume":"35","author":"Neylon","year":"2016","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2024.11.023_bib168","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1161\/CIRCHEARTFAILURE.108.814525","article-title":"The efficacy of implantable cardioverter-defibrillators in heart transplant recipients: results from a multicenter registry","volume":"2","author":"Tsai","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2024.11.023_bib169","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.hrthm.2005.06.018","article-title":"Use of the implantable cardioverter-defibrillator in long-term survivors of orthotopic heart transplantation","volume":"2","author":"Ptaszek","year":"2005","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2024.11.023_bib170","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.healun.2009.04.016","article-title":"Implantable defibrillators and cardiac resynchronization therapy in heart transplant recipients: results of a national survey","volume":"28","author":"McDowell","year":"2009","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2024.11.023_bib171","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad126","article-title":"Sudden cardiac death after heart transplantation: a population-based study","volume":"25","author":"Bonnet","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2024.11.023_bib172","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/eurheartj\/ehn020","article-title":"Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure","volume":"29","author":"Borggrefe","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.023_bib173","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejheart.2005.05.011","article-title":"Cardiac contractility modulation by non-excitatory currents: studies in isolated cardiac muscle","volume":"8","author":"Brunckhorst","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2024.11.023_bib174","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.jacc.2005.05.093","article-title":"Electrical signals applied during the absolute refractory period: an investigational treatment for advanced heart failure in patients with normal QRS duration","volume":"46","author":"Lawo","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib175","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrcardio.2013.114","article-title":"Cardiac contractility modulation therapy in advanced systolic heart failure","volume":"10","author":"Lyon","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib176","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/ejhf.1349","article-title":"Cardiac contractility modulation: mechanisms of action in heart failure with reduced ejection fraction and beyond","volume":"21","author":"Tsch\u00f6pe","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2024.11.023_bib177","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jchf.2018.04.010","article-title":"A\u00a0Randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation","volume":"6","author":"Abraham","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2024.11.023_bib178","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cardfail.2014.09.011","article-title":"A\u00a0randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with moderately reduced left ventricular ejection fraction and a narrow QRS duration: study rationale and design","volume":"21","author":"Abraham","year":"2015","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2024.11.023_bib179","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ahj.2010.10.025","article-title":"A\u00a0randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure","volume":"161","author":"Kadish","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2024.11.023_bib180","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.hrthm.2006.06.031","article-title":"Nonexcitatory, cardiac contractility modulation electrical impulses: feasibility study for advanced heart failure in patients with normal QRS duration","volume":"3","author":"Neelagaru","year":"2006","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2024.11.023_bib181","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006512","article-title":"Safety, performance, and efficacy of cardiac contractility modulation delivered by the 2-lead optimizer smart system: The FIX-HF-5C2 study","volume":"13","author":"Wiegn","year":"2020","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2024.11.023_bib182","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1002\/ehf2.12902","article-title":"A\u00a0comprehensive individual patient data meta-analysis of the effects of cardiac contractility modulation on functional capacity and heart failure-related quality of life","volume":"7","author":"Giallauria","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacc.2024.11.023_bib183","series-title":"Implantable Pulse Generator, OPTIMIZER Smart System","year":"2019"},{"key":"10.1016\/j.jacc.2024.11.023_bib184","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.023_bib185","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1056\/NEJMoa2300080","article-title":"A\u00a0dual-chamber leadless pacemaker","volume":"388","author":"Knops","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.023_bib186","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/eurheartj\/eht150","volume":"34","author":"Brignole","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.023_bib187","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1540-8159.2011.03150.x","article-title":"The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009--a World Society of Arrhythmia's project","volume":"34","author":"Mond","year":"2011","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib188","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/eurheartj\/eht511","article-title":"Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark","volume":"35","author":"Kirkfeldt","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.023_bib189","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/pace.13458","article-title":"Meta-analysis of the incidence of lead dislodgement with conventional and leadless pacemaker systems","volume":"41","author":"Wang","year":"2018","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib190","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/j.jacc.2005.02.037","article-title":"Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads","volume":"45","author":"Lin","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib191","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa1511643","article-title":"A\u00a0leadless intracardiac transcatheter pacing system","volume":"374","author":"Reynolds","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.023_bib192","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/pace.13752","article-title":"Incidence and outcomes of systemic infections in patients with leadless pacemakers: data from the Micra IDE study","volume":"42","author":"El-Chami","year":"2019","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib193","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.hrthm.2018.08.005","article-title":"Updated performance of the Micra transcatheter pacemaker in the real-world setting: A comparison to the investigational study and a transvenous historical control","volume":"15","author":"El-Chami","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2024.11.023_bib194","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1093\/europace\/euz230","article-title":"Patient selection, pacing indications, and subsequent outcomes with de novo leadless single-chamber VVI pacing","volume":"21","author":"Piccini","year":"2019","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2024.11.023_bib195","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jacep.2019.10.017","article-title":"Atrioventricular synchronous pacing using a leadless ventricular pacemaker: results from the MARVEL 2 study","volume":"6","author":"Steinwender","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib196","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.118.007124","article-title":"Impact of leadless pacemaker therapy on cardiac and atrioventricular valve function through 12 months of follow-up","volume":"12","author":"Beurskens","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib197","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.hrthm.2017.05.017","article-title":"A\u00a0leadless pacemaker in the real-world setting: The Micra Transcatheter Pacing System Post-Approval Registry","volume":"14","author":"Roberts","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2024.11.023_bib198","doi-asserted-by":"crossref","DOI":"10.1007\/s10840-023-01684-9","article-title":"Simultaneous subcutaneous implantable cardioverter-defibrillator and leadless pacemaker implantation for patients at high risk of infection: a retrospective case series report","author":"Calvagna","year":"2023","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib199","first-page":"1364","article-title":"Combined therapy with subcutaneous implantable cardiac defibrillator and leadless pacemaker in a patient with persistent left superior vena cava and mega coronary sinus: a challenging case for the best treatment","volume":"37","author":"Gatto","year":"2021","journal-title":"J\u00a0Arrhythm"},{"key":"10.1016\/j.jacc.2024.11.023_bib200","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.hroo.2023.05.004","article-title":"Design and rationale of the MODULAR ATP global clinical trial: A novel intercommunicative leadless pacing system and the subcutaneous implantable cardioverter-defibrillator","volume":"4","author":"Lloyd","year":"2023","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.jacc.2024.11.023_bib201","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.hrthm.2020.07.024","article-title":"Predictors of atrial mechanical sensing and atrioventricular synchrony with a leadless ventricular pacemaker: results from the MARVEL 2 study","volume":"17","author":"Garweg","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2024.11.023_bib202","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/jce.14445","article-title":"The long-term therapeutic effects of His-Purkinje system pacing on bradycardia and cardiac conduction dysfunction compared with right ventricular pacing: a systematic review and meta-analysis","volume":"31","author":"Sun","year":"2020","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib203","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2023.131230","article-title":"Safety and efficacy of left bundle branch area pacing compared with right ventricular pacing in patients with bradyarrhythmia and conduction system disorders: systematic review and meta-analysis","volume":"390","author":"Leventopoulos","year":"2023","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib204","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jacc.2018.10.045","volume":"74","author":"Slotwiner","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib205","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/j.jacc.2018.02.048","article-title":"Clinical outcomes of his bundle pacing compared to right ventricular pacing","volume":"71","author":"Abdelrahman","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.023_bib206","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.hrthm.2017.12.022","article-title":"Permanent his-bundle pacing: long-term lead performance and clinical outcomes","volume":"15","author":"Vijayaraman","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2024.11.023_bib207","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.hrthm.2015.03.048","article-title":"His-bundle pacing versus biventricular pacing in cardiac resynchronization therapy patients: a crossover design comparison","volume":"12","author":"Lustgarten","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2024.11.023_bib208","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.hrthm.2017.10.014","article-title":"Permanent his-bundle pacing as an alternative to biventricular pacing for cardiac resynchronization therapy: a multicenter experience","volume":"15","author":"Sharma","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2024.11.023_bib209","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/heartjnl-2018-313415","article-title":"Long-term outcomes of his bundle pacing in patients with heart failure with left bundle branch block","volume":"105","author":"Huang","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2024.11.023_bib210","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.hrthm.2019.05.011","article-title":"Prospective evaluation of feasibility and electrophysiologic and echocardiographic characteristics of left bundle branch area pacing","volume":"16","author":"Vijayaraman","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2024.11.023_bib211","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.hrthm.2021.08.033","article-title":"Clinical outcomes of left bundle branch area pacing compared to right ventricular pacing: results from the Geisinger-Rush conduction system pacing registry","volume":"19","author":"Sharma","year":"2022","journal-title":"Heart Rhythm"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109724105104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109724105104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T01:52:46Z","timestamp":1774403566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109724105104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":210,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0735109724105104"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2024.11.023","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ACC\/AHA\/ASE\/HFSA\/HRS\/SCAI\/SCCT\/SCMR 2025 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Pacing","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2024.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American College of Cardiology Foundation","name":"copyright","label":"Copyright"}]}}